Introduction: Machine learning can enable the development of predictive models that incorporate multiple variables for a systems approach to organ allocation. We explored the principle of Bayesian Belief Network (BBN) to determine whether a predictive model of graft survival can be derived using pretransplant variables. Our hypothesis was that pretransplant donor and recipient variables, when considered together as a network, add incremental value to the classification of graft survival. Methods: We performed a retrospective analysis of 5,144 randomly selected patients (age ≥18, deceased donor kidney only, first-time recipients) from the United States Renal Data System database between 2000 and 2001. Using this dataset, we developed a machine-learned BBN that functions as a pretransplant organ-matching tool. Results: A network of 48 clinical variables was constructed and externally validated using an additional 2,204 patients of matching demographic characteristics. This model was able to predict graft failure within the first year or within 3 years (sensitivity 40%; specificity 80%; area under the curve, AUC, 0.63). Recipient BMI, gender, race, and donor age were amongst the pretransplant variables with strongest association to outcome. A 10-fold internal cross-validation showed similar results for 1-year (sensitivity 24%; specificity 80%; AUC 0.59) and 3-year (sensitivity 31%; specificity 80%; AUC 0.60) graft failure. Conclusion: We found recipient BMI, gender, race, and donor age to be influential predictors of outcome, while wait time and human leukocyte antigen matching were much less associated with outcome. BBN enabled us to examine variables from a large database to develop a robust predictive model.

1.
Patel S, Cassuto J, Orloff M, et al: Minimizing morbidity of organ donation: analysis of factors for perioperative complications after living-donor nephrectomy in the United States. Transplantation 2008;85:561.
2.
United States Renal Data System, Researcher’s Guide to the USRDS Database. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007 and 2011.
3.
Akl A, Ismail AM, Ghoneim M: Prediction of graft survival of living-donor kidney transplantation: nomograms or artificial neural networks? Transplantation 2008;86:1401.
4.
Goldfarb-Rumyantzev AS, Scandling JD, Pappas L, Smout R, Horn SD: Prediction of 3-yr cadaveric graft survival based on pre-transplant variables in a large national dataset. Clin Transplant 2003;17:485.
5.
Krikov S, Khan A, Baird BC, et al: Predicting kidney transplant survival using tree-based modeling. ASAIO J 2007;53:592.
6.
Banerjee R, Das A, Ghoshal UC, Sinha M: Predicting mortality in patients with cirrhosis of liver with application of neural network technology. J Gastroenterol Hepatol 2003;18:1054.
7.
Hoot N, Aronsky D: Using Bayesian networks to predict survival of liver transplant patients. AMIA Annu Symp Proc 2005;2005:345.
8.
Grunkemeier GL, Payne N: Bayesian analysis: a new statistical paradigm for new technology. Ann Thorac Surg 2002;74:1901.
9.
Kazi JI, Furness PN, Nicholson M: Diagnosis of early acute renal allograft rejection by evaluation of multiple histological features using a Bayesian belief network. J Clin Pathol 1998;51:108.
10.
How good are the data? USRDS data validation special study. Am J Kidney Dis 1992;20(suppl 2):68.
11.
Moraleda J: New algorithms, data structures, and user interfaces for machine learning of large datasets with applications. Stanford University, 2004:xvi.
12.
Brier ME, Ray PC, Klein JB: Prediction of delayed renal allograft function using an artificial neural network. Nephrol Dial Transplant 2003;18:2655.
13.
Lin RS, Horn SD, Hurdle JF, Goldfarb-Rumyantzev AS: Single and multiple time-point prediction models in kidney transplant outcomes. J Biomed Informatics 2008;41:944.
14.
Tiong HY, Goldfarb DA, Kattan MW, et al: Nomograms for predicting graft function and survival in living donor kidney transplantation based on the UNOS Registry. J Urol 2009;181:1248.
15.
Collins MG, Chang SH, Russ GR, McDonald SP: Outcomes of transplantation using kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 2005. Transplantation 2009;87:1201.
16.
Stratta RJ, Sundberg AK, Rohr MS, et al: Optimal use of older donors and recipients in kidney transplantation. Surgery 2006;139:324.
17.
Lee CM, Carter JT, Randall HB, et al: The effect of age and prolonged cold ischemia times on the national allocation of cadaveric renal allografts. J Surg Res 2000;91:83.
18.
Hennige M, Kohler CO, Opelz G: Multivariate prediction model of kidney transplant success rates. Transplantation 1986;42:491.
19.
Pessione F, Cohen S, Durand D, et al: Multivariate analysis of donor risk factors for graft survival in kidney transplantation. Transplantation 2003;75:361.
20.
Su X, Zenios SA, Chertow GM: Incorporating recipient choice in kidney transplantation. J Am Soc Nephrol 2004;15:1656.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.